Recently, another new achievement was reached by the professional team of Virginia Contract Research Organization Co., Ltd. (VCRO). A startup biotech company, which was assisted by VCRO, was granted ODD for an autologous immune cell product for preventing recurrence of HCC from the FDA. This ODD grant is a proof of the professional in the new drug development of VCRO. The professional, integrated, and local team of VCRO helps our customers to achieve the product in the niche of strategy.
Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA!
Recently, another new achievement was reached by the professional team of Virginia Contract Research Organization Co., Ltd. (VCRO). A startup biotech company, which was assisted by VCRO, was granted ODD for an autologous immune cell product for preventing recurrence of HCC from the FDA. This ODD grant is a proof of the professional in the…